Table 3.
Comparisons of Glycated Hemoglobin Goal* Achievement Rates by Place of Birth, United States vs. Elsewhere, in the ACCORD Trial
| Intensive arm | Standard arm | |||||
|---|---|---|---|---|---|---|
| United States born (N = 60) | Elsewhere Born (N = 225) | p-value | United States born (N = 73) | Elsewhere Born (N = 211) | p-value | |
| N (%) at goal at baseline | 1 ( 2 ) | 4 ( 2 ) | 1.00 | 21 ( 29 ) | 60 ( 28) | 0.96 |
| N (%) ever achieved goal† | 46 ( 77 ) | 147 ( 65 ) | 0.10 | 69 ( 95 ) | 183 ( 87 ) | 0.07 |
| N (%) relapsed from goal‡ | 31 ( 67 ) | 112 ( 76 ) | 0.23 | 52 ( 75 ) | 119 ( 65 ) | 0.12 |
| Median time to achievement of goal, days‡ | 231 | 251 | 0.01 | 119 | 118 | 0.64 |
*Glycated hemoglobin goal refers to <6.5 for the intensive arm and 7–7.9, inclusive, for the standard arm † Ever had a measured hemoglobin of >6.5/>7.9 among those who first achieved goal in their respective treatment arms
‡ Time to first glycated hemoglobin goal achievement; if <6.5/<7.9 at baseline, time to achievement = 0 days